
Industrial & Financial Services · NSE / BSE
Founded in 2007, Jupiter Life Line Hospitals Limited is a leading multi-specialty healthcare provider in the Mumbai Metropolitan Region (MMR) and western India. Operating under the "Jupiter" brand, the company runs three hospitals in Thane, Pune, and Indore, with a total of 1,194 beds and a team of 1,306 doctors, including specialists, physicians, and surgeons (as of March 31, 2023). A new multi-specialty hospital is also under development in Dombivli, Maharashtra, with plans for over 500 beds. Construction began in April 2023. Jupiter Life Line Hospitals stands out for its advanced neuro-rehabilitation services in Thane and Indore, featuring robotic and computer-assisted treatments, as highlighted in the CRISIL Report. It also operates one of the few multi-organ transplant centers in Thane. All its hospitals are NABH-certified and NABL-accredited for medical testing. In Fiscal 2023, revenue from inpatient and outpatient services was distributed across its hospitals: Thane (54.18%), Pune (34.03%), and Indore (11.79%).
Price Band
₹695 – ₹735
Issue Size
₹869 Cr
Lot Size
20 shares
GMP
+33.5%
Est. Listing
₹981
at current GMP
Subscribed
63.72x
overall
Open
6 Sep 2023
Close
8 Sep 2023
Allotment
13 Sep 2023
Refund
14 Sep 2023
Demat Credit
15 Sep 2023
Listing
18 Sep 2023
Designated Registrar: Kfin Technologies Limited
Allotment Date
13 Sep 2023
Basis finalization
Refunds Initiate
14 Sep 2023
Mandate release
Demat Credit
15 Sep 2023
Shares in demat
Listing Debut
18 Sep 2023
Trading begins
Jupiter Life Line Hospitals Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹869.08 Crores. The shares are offered at a price band of ₹695 to ₹735 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 20 shares (approx. ₹14,700 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-09-15, while un-allotted funds or UPI block mandates will be released on 2023-09-14.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.